Skip to main content
    S

    Si-Bone Inc (SIBN)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $23.16
    -0.25 (-1.07%)

    Market Cap: $1.06B

    Last updated: Nov 17, 2026 at 4:21 PM ET

    Si-Bone Inc (SIBN) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Si-Bone (SIBN) has a market cap of $1.06B and an enterprise value of $1.06B. Its share count is up 3.96% from a year earlier.

    Total Valuation

    Enterprise value is 0.03% above the market cap, as debt exceeds cash.

    Market Cap$1.06B
    Enterprise Value$1.06B
    Latest price (Nov 17, 2026)$23.16

    Key Dates

    Last Earnings DateNov 2, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.95% in the quarter ended Sep 30, 2026 and grew 3.74% a year over 2 years.

    Shares Outstanding44.90M
    Shares Change (YoY)+3.96%
    Shares Change (QoQ)+0.95%
    Share Count Growth (2Y CAGR)+3.74%

    Valuation Ratios

    Sales and book value multiples are 4.7x and 5.6x. Its year-end P/S ranged from 3.5x to 11.9x from 2018 to 2025.

    P/S Ratio4.7x
    Forward P/S4.5x
    P/B Ratio5.6x
    P/OCF Ratio173.6x

    Valuation history and multiples

    Price Statistics

    The stock is up 32.95% over 52 weeks and trades 12.65% above its 50-day average.

    Beta (1Y)0.74
    52-Week Change+32.95%
    1-Month Change+17.80%
    3-Month Change+16.32%
    6-Month Change+56.06%
    5-Year Change-5.85%
    Total Return (1Y)+32.95%
    Total Return (3Y CAGR)+9.71%
    Total Return (5Y CAGR)+1.44%
    Return vs SPY (1Y)+14.58%
    Max Drawdown (1Y)-45.75%
    Max Drawdown (3Y)-46.20%
    Sharpe Ratio (1Y)0.48
    Correlation with SPY (1Y)0.21
    50-Day Average$20.56
    200-Day Average$16.82
    52-Week Range$11.48 to $25.92
    RSI (14 Days)54.5
    Average Volume (20 Days)958.32K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 7.58x current liabilities, and total debt is 0.19x shareholder equity.

    Current Ratio7.58x
    Quick Ratio6.15x
    Debt / Equity0.19x
    Interest Coverage-6.89x

    Returns and Efficiency

    Return on invested capital is -6.00% over the last 12 months, against a 5-year average of -8.28%.

    Return on Equity (ROE)-7.41%
    Return on Assets (ROA)-5.33%
    Return on Invested Capital (ROIC)-6.00%
    ROE (5Y Average)-31.83%
    ROA (5Y Average)-21.74%
    ROIC (5Y Average)-8.28%
    Asset Turnover0.90x
    Inventory Turnover1.13x
    Receivables Turnover7.04x
    Cash Conversion Cycle300 days

    Scores

    SIBN has an Altman Z-Score of 7.69, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score7.69
    Altman Z ZoneSafe
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $220.65M over the last 12 months is up 13.99% from the 12 months before.

    Revenue$220.65M
    Revenue Growth (YoY)+13.99%
    Gross Profit$175.19M
    Operating Income-$16.71M
    Pretax Income-$13.71M
    Net Income-$13.69M
    EBITDA-$12.16M
    Reported EPS (TTM)-$0.31

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 71.92% of the $256.77M in total assets.

    Cash and Equivalents$35.31M
    Total Debt$35.66M
    Net Debt$346.00K
    Net Debt Per Share$0.01
    Working Capital$195.03M
    Shareholder Equity$184.68M
    Book Value Per Share$4.11
    Total Assets$256.77M
    Total Liabilities$72.09M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $10.28M of capital spending, operating cash flow left -$4.19M of free cash flow.

    Operating Cash Flow$6.08M
    Capital Expenditures$10.28M
    Free Cash Flow-$4.19M
    FCF Per Share-$0.09
    Depreciation and Amortization$8.68M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -7.57%, against a 5-year average of -35.86%.

    Gross Margin79.40%
    Operating Margin-7.57%
    Pretax Margin-6.22%
    Net Margin-6.20%
    EBITDA Margin-5.51%
    FCF Margin-1.90%
    Gross Margin (5Y Average)82.21%
    Operating Margin (5Y Average)-35.86%
    Net Margin (5Y Average)-35.88%

    Growth

    Revenue grew 23.60% a year over 3 years.

    Revenue Growth (3Y CAGR)+23.60%
    Revenue Growth (5Y CAGR)+22.32%
    Book Value Per Share Growth (2Y CAGR)-1.13%
    Tangible Book Per Share Growth (2Y CAGR)-1.13%

    Revenue and profit by year

    Dividends and Yields

    SIBN does not pay a dividend. Its free cash flow yield is -0.40%.

    FCF Yield-0.40%
    Buyback Yield-0.06%
    Shareholder Yield-0.06%

    Peer Position

    Against 12 similar companies, SIBN has the 5th highest P/S.

    P/S Ratio4.7x vs 2.7x median
    ROIC-6.00% vs -18.01% median
    Revenue Growth (Trailing 4 Quarters, YoY)+13.99% vs +12.49% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 15.52% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+15.52%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About SIBN

    What is SIBN's market cap?

    Si-Bone has a market cap of $1.06B. Its enterprise value, which adds debt and subtracts cash, is $1.06B.

    How many shares of SIBN are outstanding?

    Si-Bone has 44.90M shares outstanding. The count is up 3.96% from a year earlier.

    Does SIBN pay a dividend?

    No. Si-Bone does not pay a dividend.

    How much debt does SIBN have?

    Si-Bone has $35.66M of total debt and $35.31M of cash and equivalents, a net debt position of $346.00K.